Atrial Fibrillation in Patients Hospitalized With Heart Failure: Patient Characteristics and Outcomes From the HEARTS Registry.
M AjlanL AlmazroaKhalid F AlHabibAbdelfatah A ElasfarHussam AlfalehHanan AlbackrTarek KashourAhmad S HersiGamal A HusseinLayth MimishAli AlmasoodWaleed AlHabeebSaleh AlGhamdiMubrouk AlsharariEsmail ChakraAsif MalikRaza SoomroAbdullah GhabashiMushabab Al-MurayehAhmed AbuosaPublished in: Angiology (2017)
Effect of atrial fibrillation (AF) on short- and long-term outcomes in heart failure (HF) is controversial. Accordingly, we examined this relationship in a national multicenter project using data from the Hearts Function Assessment Registry Trial in Saudi Arabia that studied the clinical features and outcomes of patients admitted with de novo and acute on chronic HF. Out of 2593 patients with HF, 449 (17.8%) had AF at presentation. Patients with AF were more likely to be males and older (mean age 65.2 ± 15.0 vs 60.5 ± 14.8 years) to have a history of ventricular tachycardia/ventricular fibrillation (3.1% vs 1.9%) or cerebrovascular accident (15.0% vs 8.5%). However, they were less likely to have diabetes (66.0% vs 55.9%) or coronary artery disease (55.6% vs 42.3%). The 1-, 2-, and 3-year crude mortality rates were significantly higher in patients with AF (23.2% vs 18.3%, 27.4% vs 22.3%, and 27.8% vs 23.2%, respectively). However, there was no significant difference in mortality after adjusting for covariates. Thus, in patients admitted with HF, AF upon presentation was not associated with increased mortality.
Keyphrases
- atrial fibrillation
- heart failure
- catheter ablation
- acute heart failure
- oral anticoagulants
- left atrial
- left atrial appendage
- coronary artery disease
- direct oral anticoagulants
- cardiovascular events
- percutaneous coronary intervention
- case report
- end stage renal disease
- quality improvement
- type diabetes
- cardiovascular disease
- left ventricular
- newly diagnosed
- ejection fraction
- study protocol
- randomized controlled trial
- liver failure
- clinical trial
- big data
- glycemic control
- chronic kidney disease
- cardiac resynchronization therapy
- electronic health record
- prognostic factors
- skeletal muscle
- hepatitis b virus
- machine learning
- peritoneal dialysis
- artificial intelligence
- phase iii
- double blind
- data analysis
- aortic dissection